OPTHEA LTD-SPON ADR (OPT) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:OPT • US68386J2087

3.41 USD
+0.23 (+7.23%)
Last: Mar 17, 2025, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

OPT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 523 industry peers in the Biotechnology industry. Both the profitability and financial health of OPT have multiple concerns. OPT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • OPT had negative earnings in the past year.
  • OPT had a negative operating cash flow in the past year.
  • In the past 5 years OPT always reported negative net income.
  • OPT had a negative operating cash flow in each of the past 5 years.
OPT Yearly Net Income VS EBIT VS OCF VS FCFOPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M

1.2 Ratios

  • OPT has a worse Return On Assets (-175.60%) than 86.49% of its industry peers.
Industry RankSector Rank
ROA -175.6%
ROE N/A
ROIC N/A
ROA(3y)-138.57%
ROA(5y)-94.2%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OPT Yearly ROA, ROE, ROICOPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K 2K

1.3 Margins

  • OPT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OPT Yearly Profit, Operating, Gross MarginsOPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50K -100K -150K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • OPT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, OPT has more shares outstanding
  • The number of shares outstanding for OPT has been increased compared to 5 years ago.
  • Compared to 1 year ago, OPT has a worse debt to assets ratio.
OPT Yearly Shares OutstandingOPT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
OPT Yearly Total Debt VS Total AssetsOPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • OPT has an Altman-Z score of -9.32. This is a bad value and indicates that OPT is not financially healthy and even has some risk of bankruptcy.
  • OPT's Altman-Z score of -9.32 is on the low side compared to the rest of the industry. OPT is outperformed by 71.05% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -9.32
ROIC/WACCN/A
WACC9.32%
OPT Yearly LT Debt VS Equity VS FCFOPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

  • OPT has a Current Ratio of 1.57. This is a normal value and indicates that OPT is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.57, OPT is doing worse than 81.23% of the companies in the same industry.
  • OPT has a Quick Ratio of 1.57. This is a normal value and indicates that OPT is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of OPT (1.57) is worse than 80.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.57
OPT Yearly Current Assets VS Current LiabilitesOPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 16.42% over the past year.
  • OPT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.06%.
  • OPT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.88% yearly.
EPS 1Y (TTM)16.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.76%
Revenue 1Y (TTM)-25.06%
Revenue growth 3Y22.04%
Revenue growth 5Y2.88%
Sales Q2Q%-60.45%

3.2 Future

  • Based on estimates for the next years, OPT will show a very strong growth in Earnings Per Share. The EPS will grow by 24.88% on average per year.
  • OPT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 384.85% yearly.
EPS Next Y56.03%
EPS Next 2Y33.14%
EPS Next 3Y24.08%
EPS Next 5Y24.88%
Revenue Next Year-37%
Revenue Next 2Y1620.09%
Revenue Next 3Y1036.13%
Revenue Next 5Y384.85%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OPT Yearly Revenue VS EstimatesOPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
OPT Yearly EPS VS EstimatesOPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • OPT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year OPT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OPT Price Earnings VS Forward Price EarningsOPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OPT Per share dataOPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as OPT's earnings are expected to grow with 24.08% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.14%
EPS Next 3Y24.08%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • OPT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

OPTHEA LTD-SPON ADR

NASDAQ:OPT (3/17/2025, 8:00:02 PM)

3.41

+0.23 (+7.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-28
Earnings (Next)08-28
Inst Owners40.24%
Inst Owner Change-0.24%
Ins Owners1.22%
Ins Owner ChangeN/A
Market Cap524.75M
Revenue(TTM)87.90K
Net Income(TTM)-255.97M
Analysts78
Price Target6.57 (92.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3%
PT rev (3m)19.52%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-75.68%
EPS NY rev (3m)-59.98%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-20%
Revenue NY rev (3m)-40%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5969.9
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2
EYN/A
EPS(NY)-0.62
Fwd EYN/A
FCF(TTM)-1.07
FCFYN/A
OCF(TTM)-1.07
OCFYN/A
SpS0
BVpS-1.1
TBVpS-1.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -175.6%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-138.57%
ROA(5y)-94.2%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 48.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 1.57
Altman-Z -9.32
F-Score1
WACC9.32%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)21.93%
Cap/Sales(5y)17.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.76%
EPS Next Y56.03%
EPS Next 2Y33.14%
EPS Next 3Y24.08%
EPS Next 5Y24.88%
Revenue 1Y (TTM)-25.06%
Revenue growth 3Y22.04%
Revenue growth 5Y2.88%
Sales Q2Q%-60.45%
Revenue Next Year-37%
Revenue Next 2Y1620.09%
Revenue Next 3Y1036.13%
Revenue Next 5Y384.85%
EBIT growth 1Y-10.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1.69%
EBIT Next 3Y15.54%
EBIT Next 5Y22.71%
FCF growth 1Y-46.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.8%
OCF growth 3YN/A
OCF growth 5YN/A

OPTHEA LTD-SPON ADR / OPT FAQ

Can you provide the ChartMill fundamental rating for OPTHEA LTD-SPON ADR?

ChartMill assigns a fundamental rating of 2 / 10 to OPT.


Can you provide the valuation status for OPTHEA LTD-SPON ADR?

ChartMill assigns a valuation rating of 1 / 10 to OPTHEA LTD-SPON ADR (OPT). This can be considered as Overvalued.


How profitable is OPTHEA LTD-SPON ADR (OPT) stock?

OPTHEA LTD-SPON ADR (OPT) has a profitability rating of 0 / 10.


How financially healthy is OPTHEA LTD-SPON ADR?

The financial health rating of OPTHEA LTD-SPON ADR (OPT) is 1 / 10.


Can you provide the expected EPS growth for OPT stock?

The Earnings per Share (EPS) of OPTHEA LTD-SPON ADR (OPT) is expected to grow by 56.03% in the next year.